Moving -2.53% from the most recent open, shares of VistaGen Therapeutics, Inc. (:VTGN) have landed on investor watchlists as the latest bid puts the equity at $1.54. Investors interested in stocks under $5 have given this stock a second look over the past few weeks.
Most investors are likely looking for that next stock that is ready to take off running. Maybe the focus is on finding a stock that has recently taken a turn for the worse for no real apparent reason. As we all know, as quickly as a stock can drop in price, it can bounce back just as fast.
Although the popular stocks that receive a high level of media coverage tend to recover quicker after a sell-off, there may be plenty of under the radar stocks that are ripe for buying. Scoping out these potential market gems may help repair a portfolio that has taken a hit for any number of reasons.
The average investor might not have the time to monitor every single tick of a given stock, but taking a look at historical performance may help provide some valuable insight on where the stock may be trending in the future. Over the past week, VistaGen Therapeutics, Inc. (:VTGN) has performed -6.67%. For the past month, shares are -16.30%. Over the last quarter, shares have performed -15.38%. Looking back further, VistaGen Therapeutics, Inc. stock has been -26.67% over the last six months, and -58.71% since the start of the calendar year. For the past full year, shares are -60.71%.
There is rarely any substitute for diligent research, especially when it pertains to the equity markets. No matter what strategy an investor employs, keeping abreast of current market happenings is of the utmost importance. Everyone wants to see their stock picks soar, but the stark reality is that during a market wide sell-off, this may not be the case. Recently, shares of VistaGen Therapeutics, Inc. (:VTGN) have been seen trading -34.22% away from the 200-day moving average and -14.19% off the 50-day moving average. The stock is currently trading -67.16% away from the 52-week high and separated -1.28% from the 52-week low. VistaGen Therapeutics, Inc.’s RSI is presently sitting at 36.15.
New investors may sometimes be working with limited capital. Choosing which stocks to own can be a tough decision. Individuals may be deciding on whether to buy 10 shares of a stock trading at $100 as opposed to purchasing 100 shares of a stock trading at $10. We have recently been focusing on stocks that are trading under the $10 price level. We are constantly monitoring technical and fundamental factors that may lead to breakouts for these relatively cheap (in terms of price) stocks.